1944 related articles for article (PubMed ID: 26511535)
1. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial.
Kjeldsen SE; Berge E; Bangalore S; Messerli FH; Mancia G; Holzhauer B; Hua TA; Zappe D; Zanchetti A; Weber MA; Julius S
Blood Press; 2016; 25(2):83-92. PubMed ID: 26511535
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial.
Mancia G; Kjeldsen SE; Zappe DH; Holzhauer B; Hua TA; Zanchetti A; Julius S; Weber MA
Eur Heart J; 2016 Mar; 37(12):955-64. PubMed ID: 26590384
[TBL] [Abstract][Full Text] [Related]
3. Prognostic importance of pretreatment and on-treatment blood pressure: Further analysis of the ACTION database and the effect of nifedipine gastrointestinal therapeutic system.
Elliott HL; Lloyd SM; Ford I; Meredith PA
Blood Press; 2016; 25(2):67-73. PubMed ID: 26796694
[TBL] [Abstract][Full Text] [Related]
4. Importance of sustained and "tight" blood pressure control in patients with high cardiovascular risk.
Meredith PA; Lloyd SM; Ford I; Elliott HL
Blood Press; 2016; 25(2):74-82. PubMed ID: 26796355
[TBL] [Abstract][Full Text] [Related]
5. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis.
Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ
Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690
[TBL] [Abstract][Full Text] [Related]
6. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ
Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
Zanchetti A; Julius S; Kjeldsen S; McInnes GT; Hua T; Weber M; Laragh JH; Plat F; Battegay E; Calvo-Vargas C; Cieśliński A; Degaute JP; Holwerda NJ; Kobalava J; Pedersen OL; Rudyatmoko FP; Siamopoulos KC; Störset O
J Hypertens; 2006 Nov; 24(11):2163-8. PubMed ID: 17053536
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular outcomes and achieved blood pressure in patients with and without diabetes at high cardiovascular risk.
Böhm M; Schumacher H; Teo KK; Lonn EM; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder RE; Marx N; Sliwa K; Weber MA; Williams B; Yusuf S
Eur Heart J; 2019 Jul; 40(25):2032-2043. PubMed ID: 30919899
[TBL] [Abstract][Full Text] [Related]
10. Systolic and diastolic blood pressure changes in relation with myocardial infarction and stroke in patients with coronary artery disease.
Verdecchia P; Reboldi G; Angeli F; Trimarco B; Mancia G; Pogue J; Gao P; Sleight P; Teo K; Yusuf S
Hypertension; 2015 Jan; 65(1):108-14. PubMed ID: 25331850
[TBL] [Abstract][Full Text] [Related]
11. The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design.
Mann J; Julius S
Blood Press; 1998 May; 7(3):176-83. PubMed ID: 9758088
[TBL] [Abstract][Full Text] [Related]
12. Predictors of cardiac morbidity in diabetic, new-onset diabetic and non-diabetic high-risk hypertensive patients: The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial.
Aksnes TA; Kjeldsen SE; Rostrup M; Holzhauer B; Hua TA; Julius S
Blood Press; 2016 Aug; 25(4):235-40. PubMed ID: 26808585
[TBL] [Abstract][Full Text] [Related]
13. Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort.
Wokhlu A; Smith SM; Gong Y; Handberg EM; Elgendy IY; Bavry AA; Cooper-DeHoff RM; Pepine CJ
J Hypertens; 2018 Feb; 36(2):419-427. PubMed ID: 28938338
[TBL] [Abstract][Full Text] [Related]
14. Impact of lower achieved blood pressure on outcomes in hypertensive patients.
Okin PM; Hille DA; Kjeldsen SE; Dahlöf B; Devereux RB
J Hypertens; 2012 Apr; 30(4):802-10; discussion 810. PubMed ID: 22343536
[TBL] [Abstract][Full Text] [Related]
15. Could intensive anti-hypertensive therapy produce the "J-curve effect" in patients with coronary artery disease and hypertension after revascularization?
Lu W
Eur Rev Med Pharmacol Sci; 2016 Apr; 20(7):1350-5. PubMed ID: 27097958
[TBL] [Abstract][Full Text] [Related]
16. The Hypertension Optimal Treatment study and the importance of lowering blood pressure.
Hansson L
J Hypertens Suppl; 1999 Feb; 17(1):S9-13. PubMed ID: 10340838
[TBL] [Abstract][Full Text] [Related]
17. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study.
Boman K; Gerdts E; Wachtell K; Dahlöf B; Nieminen MS; Olofsson M; Papademetriou V; Devereux RB
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):242-8. PubMed ID: 19369828
[TBL] [Abstract][Full Text] [Related]
18. Achieved diastolic blood pressure and pulse pressure at target systolic blood pressure (120-140 mmHg) and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials.
Böhm M; Schumacher H; Teo KK; Lonn E; Mahfoud F; Mann JFE; Mancia G; Redon J; Schmieder R; Weber M; Sliwa K; Williams B; Yusuf S
Eur Heart J; 2018 Sep; 39(33):3105-3114. PubMed ID: 29873709
[TBL] [Abstract][Full Text] [Related]
19. Impact of blood pressure control on cardiovascular events in 26,512 Japanese hypertensive patients: the Japan Hypertension Evaluation with Angiotensin II Antagonist Losartan Therapy (J-HEALTH) study, a prospective nationwide observational study.
Shimamoto K; Fujita T; Ito S; Naritomi H; Ogihara T; Shimada K; Tanaka H; Yoshiike N;
Hypertens Res; 2008 Mar; 31(3):469-78. PubMed ID: 18497466
[TBL] [Abstract][Full Text] [Related]
20. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
